VERU - Veru Inc Company Long-Term Liabilities

Public company logo of Veru Inc (VERU)

The price action of Veru Inc. (VERU) demonstrates the asset's resilience, with indicators standing at 0.00, driven by its autonomy from global crises and stable demand for biotechnology. Veru Inc. (VERU) generates revenue through the development of treatments for cancer and muscular dystrophy, where patent protection ensures a constant cash flow. The business also relies on the commercialization of women's health products, guaranteeing reliable sales in a conservative market.

verupharma.com (VERU) Company Long-Term Debt: for the period 07/04/2022 - 10/29/2026

Veru Pharma (VERU) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price verupharma.com|VERU - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Veru|VERU - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Veru|VERU - Company Book Value|Market Value to Book Value verupharma.com|VERU - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Veru Inc.|VERU - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Veru Corporation|VERU - Company Total Debt|Debts to Book Capitalization Veru|VERU - Company Long-Term Debt|Company Short-Term Loans and Borrowings Veru
Fundamental company valuation:VERU (verupharma.com)
Brand item of Veru Inc.

Veru Inc. maintains a unique market position with inelastic demand for enobosarm, allowing the company to manage financial stability through an assessment of long-term debt capital while preparing for commercialization. The current value of 0.00 reflects total liabilities with maturities exceeding one year, benchmarked against the US industry median to identify liquidity risks or the company's expansion potential.

Competitors of Veru Inc. (VERU)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Liabilities HURA (TuHURA Biosciences, Inc.)|Company Long-Term Debt TARA (protaratx.com)|Company Long-Term Debts FATE (Fate Therapeutics)|Aadi Bioscience, Inc. (WHWK) - Long-Term Debt|TCRX - Company Long-Term Debt|Company Long-Term Loans and Borrowings CSBR (Champions Oncology)|XBIT (xbiotech.com) - Company Long-Term Liabilities|CEL-SCI (CVM) - Company Long-Term Debts|Company Long-Term Liabilities OSTX|RADX: Company Long-Term Loans and Borrowings|Company Long-Term Debts ARTV|Long-Term Debt Volume adlainortye.com|Company Long-Term Debt Tempest Therapeutics TPST|XLO: Company Long-Term Indebtedness|Enochian BioSciences - Company Long-Term Debts|Mural Oncology plc (MURA) - Company Long-Term Liabilities|KAPA (kairospharma.com) - Company Long-Term Liabilities|OKUR - Long-Term Debt Volume|Company Long-Term Liabilities GDTC|Company Long-Term Debt CRIS|Company Long-Term Debts APLM|THAR - Long-Term Debt|Company Long-Term Debt Advanced Biomed ADVB|Company Long-Term Loans and Borrowings GNPX|CLDI: Company Long-Term Liabilities|SBFM - Company Long-Term Debts|XBIO: Company Long-Term Debts|Company Long-Term Liabilities Salarius Pharmaceuticals Inc|PPBT (Purple Biotech Corp) - Company Long-Term Debts|Company Long-Term Debts AON|Company Long-Term Debt BeiGene, Ltd. (BGNE)|checkpointtx.com - Company Long-Term Indebtedness|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|ICAD - Company Long-Term Liabilities|Ikena - Company Long-Term Debts|Long-Term Debt Notable Labs Corp|viracta.com (VIRX) - Company Long-Term Debt|morphosys.com - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities NAYA|AAPGV: Company Long-Term Loans and Borrowings